CMO and CDMO are different conversations

In meetings the two abbreviations get used as if they were the same building. They are not. A CMO, a contract manufacturing organisation, takes a product you have already specified and makes it on an agreed line. A CDMO, a contract development and manufacturing organisation, is in the room earlier: formulation work, scale-up, method transfer, then the commercial batch. Using the wrong word does not offend anyone. It does send the project to the wrong person inside the plant.

The Pharma Partners Private Limited coordinates these arrangements. We do not run the manufacturing block, and we do not sign the batch record. We make sure the company with the product and the company with the plant are talking about the same scope, on a calendar both of them can keep.

Where coordination actually fails

It fails in the handover between commercial and technical. The business team agrees a price per strip. The plant’s formulation team has not seen the target dissolution. The marketing team wants a smaller pack by the next doctor campaign. The stability protocol was written for the old pack. Nobody is lying. Everybody is working off a different version of the product.

We put one scope note in the middle. Dosage form, strength, pack, expected batch size, what is already developed, and what is still a wish. If development work is still open, we call it a CDMO conversation and we stop pretending the price per strip is final. If the product is already commercial somewhere else and this plant is only reproducing it, we call it a CMO conversation and we ask for the technology-transfer pack before anyone debates credit days.

Capacity is the other quiet failure. A liquid line that is free in a presentation can be blocked by a campaign product from an older customer. We ask for a window, not a capability list. “We have a liquid block” and “we can take a 5,000-litre batch in November” are different sentences. Only one of them belongs in a plan.

What we stay for

The introduction is the easy morning. The longer work is the document chase between the two quality teams, the artwork that has to match the permission, and the commercial term that was left as “standard”. Standard means something different in every plant. We write the version this plant means: delivery point, who pays for the freight, what happens to a rejected batch, how many days before a firm order the plant needs the raw material on site.

If your own team is already deep in a technical transfer, you may not need us in the chemistry. You may still need someone watching the commercial thread so it does not die while the analysts are busy. That is a fair use of us. So is the earlier moment, when you know you need a third-party plant and you do not yet know whether you need development or only capacity.

Send the dosage form, the stage you are at, and the month you want a commercial batch. info@thepharmapartners.com or +91 95056 51342. We will tell you whether we know a plant worth the visit.